Laden…
[1-(5-fluoropentyl)indol-3-yl]-naphthalen-1-ylmethanone
AM-2201 is a substance from the class of naphthoylindoles. Further information will follow after enrichment.
Class
Cannabinoide
Pharmacological context
Mechanism
CB1 agonist, CB2 agonist
Short read on known pharmacology
Interactions
No curated pairs visible
Curated visible combinations
Risk theme
Interpret risks carefully
Condensed from structured notes
Translation in progress
The German version has more complete content. This English page is being expanded; safety-critical risk and interaction sections may still appear while translation continues.
Receptor Targets
Mechanism of Action
AM-2201 acts through the following pharmacological mechanisms:
Designations
IUPAC: [1-(5-fluoropentyl)indol-3-yl]-(1-naphthyl)methanone
Legal Status
Legal status not verified by official sources. Please check current legislation independently.
Information without guarantee. Not legal advice.
Receptor Profile
Der CB1-Rezeptor ist ein Gi/Go-gekoppelter Cannabinoidrezeptor, der vorwiegend im zentralen Nervensystem exprimiert wird. Er moduliert Neurotransmitterfreisetzung und ist Teil des Endocannabinoidsystems.
Der CB2-Rezeptor ist ein Gi-gekoppelter Cannabinoidrezeptor, der hauptsächlich auf Immunzellen und in geringerem Maße im ZNS exprimiert wird. Er moduliert Entzündungsprozesse und Immunantworten.
Substance Fingerprint
Pharmacological profile based on receptor binding, mechanism of action, and substance class. Limited data — interpret profile with caution.
Synapedia Evidence
Effects & Pharmacology translation in progress
English prose is being expanded. The German version currently has more detail.
Reported range 5–10 mg
Total duration 2–4 hours
Geraucht
| Tier | Dosage |
|---|---|
| Light | 1–5 mg |
| Reported | 5–10 mg |
| Strong | 10–20 mg |
Geraucht
Onset
5–10 minutes
Peak
30–60 minutes
Total duration
2–4 hours
After effects
1–2 hours
Avoid uncertain dosage claims and do not infer numbers when data is unclear.
Dose sensitivity varies greatly between individuals. Body weight, tolerance, route of administration, combinations, and pre-existing conditions significantly affect outcomes. These figures are not dosing recommendations — they describe reported ranges, not safe amounts.
Risks
Summary
Mögliche Risiken sind psychische Effekte und unerwünschte physiologische Reaktionen.
Safer Use
The risks listed may be incomplete. Especially for research chemicals and rare substances, available data is limited.
Interaction details from the knowledge layer are still being translated.
Interaction data is based on known mechanisms. Unknown or rare interactions are possible and may be life-threatening.
Based on substance class, receptors, mechanisms, and effect profile.
This information is for scientific and harm-reduction purposes only. It does not constitute medical advice.
Share a report, observation, or question about this substance. Entries are reviewed before publication and marked as unverified community signals.
These entries are submitted by users and are not verified. They may contain subjective experiences, observations, source leads, or corrections. They do not replace scientific data and are not consumption advice.
The signal hub collects approved risk signals, experience reports and source leads by relevance.